Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs

Current Cancer Drug Targets

Volumn 6, Issue 2, 2006, Pages 107-121

  Klampfer, Lidija ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BUTYRIC ACID; CAMPTOTHECIN; CISPLATIN; CPA 1; CPA 7; CUCURBITACIN A; CUCURBITACIN I; CUCURBITACIN Q; CURCUMIN; DELTA15 PROSTAGLANDIN J2; DOXORUBICIN; GEFITINIB; JANUS KINASE; JANUS KINASE INHIBITOR I; JSI 124; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; RITUXIMAB; ROSIGLITAZONE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; SULINDAC; TRANSCRIPTION FACTOR; TYROSINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DRUG MECHANISM; DRUG TARGETING; ENZYME REGULATION; FUNCTIONAL PROTEOMICS; HOMEOSTASIS; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; MUTAGENESIS; NONHUMAN; PHENOTYPE; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UBIQUITINATION; ANIMAL; DRUG EFFECT; GENETIC TRANSCRIPTION; NEOPLASM; PATHOPHYSIOLOGY;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 33645839013     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800906776056491     Document Type: Review

References (148)

1. Hanahan, D.; Weinberg, R. A. The Hallmarks of Cancer. Cell 2000, 100, 57-70.
2. Darnell, J. E., Jr. Transcription Factors as Targets for Cancer Therapy. Nat. Rev. Cancer 2002, 2, 740-749.
3. Yamaoka, K.; Saharinen, P.; Pesu, M.; Holt, V. E., 3rd; Silvennoinen, O.; O'Shea, J. J. The Janus Kinases (Jaks). Genome Biol. 2004, 5, 253.
4. Horvath, C. M.; Wen, Z.; Darnell, J. E., Jr. A Stat Protein Domain That Determines DNA Sequence Recognition Suggests a Novel DNA-Binding Domain. Genes Dev. 1995, 9, 984-994.
5. Shuai, K.; Horvath, C. M.; Huang, L. H.; Qureshi, S. A.; Cowburn, D.; Darnell, J. E., Jr. Interferon Activation of the Transcription Factor Stat91 Involves Dimerization through Sh2-Phosphotyrosyl Peptide Interactions. Cell 1994, 76, 821-828.
6. Gupta, S.; Yan, H.; Wong, L. H.; Ralph, S.; Krolewski, J.; Schindler, C. The Sh2 Domains of Stat1 and Stat2 Mediate Multiple Interactions in the Transduction of Ifn-Alpha Signals. Embo J. 1996, 15, 1075-1084.
7. Wen, Z.; Darnell, J. E., Jr. Mapping of Stat3 Serine Phosphorylation to a Single Residue (727) and Evidence That Serine Phosphorylation Has No Influence on DNA Binding of Stat1 and Stat3. Nucleic Acids Res. 1997, 25, 2062-2067.
8. Bromberg, J. F.; Horvath, C. M.; Wen, Z.; Schreiber, R. D.; Darnell, J. E., Jr. Transcriptionally Active Stat1 Is Required for the Antiproliferative Effects of Both Interferon Alpha and Interferon Gamma. Proc. Natl. Acad. Sci. USA 1996, 93, 7673-7678.
9. McBride, K. M.; Banninger, G.; McDonald, C.; Reich, N. C. Regulated Nuclear Import of the Stat1 Transcription Factor by Direct Binding of Importin-Alpha. Embo J. 2002, 21, 1754-1763.
10. McBride, K. M.; McDonald, C.; Reich, N. C. Nuclear Export Signal Located within Thedna-Binding Domain of the Stat1transcription Factor. Embo J. 2000, 19, 6196-6206.
11. Haspel, R. L.; Salditt-Georgieff, M.; Darnell, J. E., Jr. The Rapid Inactivation of Nuclear Tyrosine Phosphorylated Stat1 Depends Upon a Protein Tyrosine Phosphatase. Embo J. 1996, 15, 6262-6268.
12. Haspel, R. L.; Darnell, J. E., Jr. A Nuclear Protein Tyrosine Phosphatase Is Required for the Inactivation of Stat1. Proc. Natl. Acad. Sci. USA 1999, 96, 10188-10193.
13. Chatterjee-Kishore, M.; Wright, K. L.; Ting, J. P.; Stark, G. R. How Stat1 Mediates Constitutive Gene Expression: A Complex of Unphosphorylated Stat1 and Irf1 Supports Transcription of the Lmp2 Gene. Embo J. 2000, 19, 4111-4122.
14. Look, D. C.; Pelletier, M. R.; Tidwell, R. M.; Roswit, W. T.; Holtzman, M. J. Stat1 Depends on Transcriptional Synergy with Sp1. J. Biol. Chem. 1995, 270, 30264-30267.
15. Stephanou, A.; Latchman, D. S. Transcriptional Regulation of the Heat Shock Protein Genes by Stat Family Transcription Factors. Gene Expr. 1999, 7, 311-319.
16. Yang, J.; Chatterjee-Kishore, M.; Staugaitis, S. M.; Nguyen, H.; Schlessinger, K.; Levy, D. E.; Stark, G. R. Novel Roles of Unphosphorylated Stat3 in Oncogenesis and Transcriptional Regulation. Cancer Res. 2005, 65, 939-947.
17. Naka, T.; Narazaki, M.; Hirata, M.; Matsumoto, T.; Minamoto, S.; Aono, A.; Nishimoto, N.; Kajita, T.; Taga, T.; Yoshizaki, K.; Akira, S.; Kishimoto, T. Structure and Function of a New Stat-Induced Stat Inhibitor. Nature 1997, 387, 924-929.
18. Yoshimura, A. The Cis Family: Negative Regulators of Jak-Stat Signaling. Cytokine Growth Factor Rev. 1998, 9, 197-204.
19. Croker, B. A.; Krebs, D. L.; Zhang, J. G.; Wormald, S.; Willson, T. A.; Stanley, E. G.; Robb, L.; Greenhalgh, C. J.; Forster, I.; Clausen, B. E.; Nicola, N. A.; Metcalf, D.; Hilton, D. J.; Roberts, A. W.; Alexander, W. S. Socs3 Negatively Regulates Il-6 Signaling in Vivo. Nat. Immunol. 2003, 4, 540-545.
20. Oshimo, Y.; Kuraoka, K.; Nakayama, H.; Kitadai, Y.; Yoshida, K.; Chayama, K.; Yasui, W. Epigenetic Inactivation of Socs-1 by Cpg Island Hypermethylation in Human Gastric Carcinoma. Int. J. Cancer 2004, 112, 1003-1009.
21. Fujitake, S.; Hibi, K.; Okochi, O.; Kodera, Y.; Ito, K.; Akiyama, S.; Nakao, A. Aberrant Methylation of Socs-1 Was Observed in Younger Colorectal Cancer Patients. J. Gastroenterol. 2004, 39, 120-124.
22. He, B.; You, L.; Uematsu, K.; Zang, K.; Xu, Z.; Lee, A. Y.; Costello, J. F.; McCormick, F.; Jablons, D. M. Socs-3 Is Frequently Silenced by Hypermethylation and Suppresses Cell Growth in Human Lung Cancer. Proc. Natl. Acad. Sci. USA 2003, 100, 14133-14138.
23. You, M.; Yu, D. H.; Feng, G. S. Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/Stat Pathway. Mol. Cell Biol. 1999, 19, 2416-2424.
24. Oka, T.; Ouchida, M.; Koyama, M.; Ogama, Y.; Takada, S.; Nakatani, Y.; Tanaka, T.; Yoshino, T.; Hayashi, K.; Ohara, N.; Kondo, E.; Takahashi, K.; Tsuchiyama, J.; Tanimoto, M.; Shimizu, K.; Akagi, T. Gene Silencing of the Tyrosine Phosphatase Shp1 Gene by Aberrant Methylation in Leukemias/Lymphomas. Cancer Res. 2002, 62, 6390-6394.
25. Ungureanu, D.; Saharinen, P.; Junttila, I.; Hilton, D. J.; Silvennoinen, O. Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with Socs-1. Mol. Cell Biol. 2002, 22, 3316-3326.
26. Malakhov, M. P.; Kim, K. I.; Malakhova, O. A.; Jacobs, B. S.; Borden, E. C.; Zhang, D. E. High-Throughput Immunoblotting. Ubiquitiin-Like Protein Isg15 Modifies Key Regulators of Signal Transduction. J. Biol. Chem. 2003, 278, 16608-16613.
27. Malakhova, O. A.; Yan, M.; Malakhov, M. P.; Yuan, Y.; Ritchie, K. J.; Kim, K. I.; Peterson, L. F.; Shuai, K.; Zhang, D. E. Protein Isgylation Modulates the Jak-Stat Signaling Pathway. Genes Dev. 2003, 17, 455-460.
28. Becker, S.; Groner, B.; Muller, C. W. Three-Dimensional Structure of the Stat3beta Homodimer Bound to DNA. Nature 1998, 394, 145-151.
29. Chen, X.; Vinkemeier, U.; Zhao, Y.; Jeruzalmi, D.; Darnell, J. E., Jr.; Kuriyan, J. Crystal Structure of a Tyrosine Phosphorylated Stat-1 Dimer Bound to DNA. Cell 1998, 93, 827-839.
30. Shuai, K.; Schindler, C.; Prezioso, V. R.; Darnell, J. E., Jr. Activation of Transcription by Ifn-Gamma: Tyrosine Phosphorylation of a 91-Kd DNA Binding Protein. Science 1992, 258, 1808-1812.
31. Schindler, C.; Shuai, K.; Prezioso, V. R.; Darnell, J. E., Jr. Interferon-Dependent Tyrosine Phosphorylation of a Latent Cytoplasmic Transcription Factor. Science 1992, 257, 809-813.
32. Decker, T.; Kovarik, P. Serine Phosphorylation of Stats. Oncogene 2000, 19, 2628-2637.
33. Frank, D. A.; Mahajan, S.; Ritz, J. B Lymphocytes from Patients with Chronic Lymphocytic Leukemia Contain Signal Transducer and Activator of Transcription (Stat) 1 and Stat3 Constitutively Phosphorylated on Serine Residues. J. Clin. Invest. 1997, 100, 3140-3148.
34. Horvai, A. E.; Xu, L.; Korzus, E.; Brard, G.; Kalafus, D.; Mullen, T. M.; Rose, D. W.; Rosenfeld, M. G.; Glass, C. K. Nuclear Integration of Jak/Stat and Ras/Ap-1 Signaling by Cbp and P300. Proc. Natl. Acad. Sci. USA 1997, 94, 1074-1079.
35. Klampfer, L.; Huang, J.; Swaby, L. A.; Augenlicht, L. Requirement of Histone Deacetylase Activity for Signaling by Stat1. J. Biol. Chem. 2004, 279, 30358-30368.
36. Nusinzon, I.; Horvath, C. M. Interferon-Stimulated Transcription and Innate Antiviral Immunity Require Deacetylase Activity and Histone Deacetylase 1. Proc. Natl. Acad. Sci. USA 2003, 100, 14742-14747.
37. Chang, H. M.; Paulson, M.; Holko, M.; Rice, C. M.; Williams, B. R.; Marie, I.; Levy, D. E. Induction of Interferon-Stimulated Gene Expression and Antiviral Responses Require Protein Deacetylase Activity. Proc. Natl. Acad. Sci. USA 2004, 101, 9578-9583.
38. Khochbin, S.; Verdel, A.; Lemercier, C.; Seigneurin-Berny, D. Functional Significance of Histone Deacetylase Diversity. Curr. Opin. Genet. Dev. 2001, 11, 162-166.
39. Klampfer, L.; Huang, J.; Sasazuki, T.; Shirasawa, S.; Augenlicht, L. Inhibition of Interferon Gamma Signaling by the Short Chain Fatty Acid Butyrate. Mol. Cancer Res. 2003, 1, 855-862.
40. Sakamoto, S.; Potla, R.; Larner, A. C. Histone Deacetylase Activity Is Required to Recruit Rna Polymerase Ii to the Promoters of Selected Interferon-Stimulated Early Response Genes. J. Biol. Chem. 2004, 279, 40362-40367.
41. Rascle, A.; Johnston, J. A.; Amati, B. Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by Stat5. Mol. Cell Biol. 2003, 23, 4162-4173.
42. Shankaranarayanan, P.; Chaitidis, P.; Kuhn, H.; Nigam, S. Acetylation by Histone Acetyltransferase Creb-Binding Protein/P300 of Stat6 Is Required for Transcriptional Activation of the 15-Lipoxygenase-1 Gene. J. Biol. Chem. 2001, 276, 42753-42760.
43. McDonald, C.; Reich, N. C. Cooperation of the Transcriptional Coactivators Cbp and P300 with Stat6. J. Interferon. Cytokine Res. 1999, 19, 711-722.
44. Yuan, Z. L.; Guan, Y. J.; Chatterjee, D.; Chin, Y. E. Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue. Science 2005, 307, 269-273.
45. Munarriz, E.; Barcaroli, D.; Stephanou, A.; Townsend, P. A.; Maisse, C.; Terrinoni, A.; Neale, M. H.; Martin, S. J.; Latchman, D. S.; Knight, R. A.; Melino, G.; De Laurenzi, V. Pias-1 Is a Checkpoint Regulator Which Affects Exit from G1 and G2 by Sumoylation of P73. Mol. Cell Biol. 2004, 24, 10593-10610.
46. Gu, F.; Dube, N.; Kim, J. W.; Cheng, A.; Ibarra-Sanchez Mde, J.; Tremblay, M. L.; Boisclair, Y. R. Protein Tyrosine Phosphatase 1b Attenuates Growth Hormone-Mediated Jak2-Stat Signaling. Mol. Cell Biol. 2003, 23, 3753-3762.
47. Bousquet, C.; Susini, C.; Melmed, S. Inhibitory Roles for Shp-1 and Socs-3 Following Pituitary Proopiomelanocortin Induction by Leukemia Inhibitory Factor. J. Clin. Invest. 1999, 104, 1277-1285.
48. Woetmann, A.; Nielsen, M.; Christensen, S. T.; Brockdorff, J.; Kaltoft, K.; Engel, A. M.; Skov, S.; Brender, C.; Geisler, C.; Svejgaard, A.; Rygaard, J.; Leick, V.; Odum, N. Inhibition of Protein Phosphatase 2a Induces Serine/Threonine Phosphorylation, Subcellular Redistribution, and Functional Inhibition of Stat3. Proc. Natl. Acad. Sci. USA 1999, 96, 10620-10625.
49. ten Hoeve, J.; de Jesus Ibarra-Sanchez, M.; Fu, Y.; Zhu, W.; Tremblay, M.; David, M.; Shuai, K. Identification of a Nuclear Stat1 Protein Tyrosine Phosphatase. Mol. Cell Biol. 2002, 22, 5662-5668.
50. Wu, T. R.; Hong, Y. K.; Wang, X. D.; Ling, M. Y.; Dragoi, A. M.; Chung, A. S.; Campbell, A. G.; Han, Z. Y.; Feng, G. S.; Chin, Y. E. Shp-2 Is a Dual-Specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in Nuclei. J. Biol. Chem. 2002, 277, 47572-47580.
51. Klampfer, L.; Huang, J.; Corner, G.; Mariadason, J.; Arango, D.; Sasazuki, T.; Shirasawa, S.; Augenlicht, L. Oncogenic Ki-Ras Inhibits the Expression of Interferon-Responsive Genes through Inhibition of Stat1 and Stat2 Expression. J. Biol. Chem. 2003, 278, 46278-46287.
52. Kamakura, S.; Oishi, K.; Yoshimatsu, T.; Nakafuku, M.; Masuyama, N.; Gotoh, Y. Hes Binding to Stat3 Mediates Crosstalk between Notch and Jak-Stat Signalling. Nat. Cell Biol. 2004, 6, 547-554.
53. Caldenhoven, E.; van Dijk, T. B.; Solari, R.; Armstrong, J.; Raaijmakers, J. A.; Lammers, J. W.; Koenderman, L.; de Groot, R. P. Stat3beta, a Splice Variant of Transcription Factor Stat3, Is a Dominant Negative Regulator of Transcription. J. Biol. Chem. 1996, 271, 13221-13227.
54. Maritano, D.; Sugrue, M. L.; Tininini, S.; Dewilde, S.; Strobl, B.; Fu, X.; Murray-Tait, V.; Chiarle, R.; Poli, V. The Stat3 Isoforms Alpha and Beta Have Unique and Specific Functions. Nat. Immunol. 2004, 5, 401-409.
55. Yoo, J. Y.; Huso, D. L.; Nathans, D.; Desiderio, S. Specific Ablation of Stat3beta Distorts the Pattern of Stat3-Responsive Gene Expression and Impairs Recovery from Endotoxic Shock. Cell 2002, 108, 331-344.
56. Hoey, T.; Zhang, S.; Schmidt, N.; Yu, Q.; Ramchandani, S.; Xu, X.; Naeger, L. K.; Sun, Y. L.; Kaplan, M. H. Distinct Requirements for the Naturally Occurring Splice Forms Stat4alpha and Stat4beta in Il-12 Responses. Embo J. 2003, 22, 4237-4248.
57. Hendry, L.; John, S. Regulation of Stat Signalling by Proteolytic Processing. Eur. J. Biochem. 2004, 271, 4613-4620.
58. Piazza, F.; Valens, J.; Lagasse, E.; Schindler, C. Myeloid Differentiation of Fdcp1 Cells Is Dependent on Stat5 Processing. Blood 2000, 96, 1358-1365.
59. Ouchi, T.; Lee, S. W.; Ouchi, M.; Aaronson, S. A.; Horvath, C. M. Collaboration of Signal Transducer and Activator of Transcription 1 (Stat1) and Brca1 in Differential Regulation of Ifn-Gamma Target Genes. Proc. Natl. Acad. Sci. USA 2000, 97, 5208-5213.
60. Townsend, P. A.; Scarabelli, T. M.; Davidson, S. M.; Knight, R. A.; Latchman, D. S.; Stephanou, A. Stat-1 Interacts with P53 to Enhance DNA Damage-Induced Apoptosis. J. Biol. Chem. 2004, 279, 5811-5820.
61. Zhu, M.; John, S.; Berg, M.; Leonard, W. J. Functional Association of Nmi with Stat5 and Stat1 in Il-2- and Ifngamma-Mediated Signaling. Cell 1999, 96, 121-130.
62. Zhang, X.; Wrzeszczynska, M. H.; Horvath, C. M.; Darnell, J. E., Jr. Interacting Regions in Stat3 and C-Jun That Participate in Cooperative Transcriptional Activation. Mol. Cell Biol. 1999, 19, 7138-7146.
63. Yu, Z.; Zhang, W.; Kone, B. C. Signal Transducers and Activators of Transcription 3 (Stat3) Inhibits Transcription of the Inducible Nitric Oxide Synthase Gene by Interacting with Nuclear Factor Kappab. Biochem. J. 2002, 367, 97-105.
64. Nakajima, H.; Brindle, P. K.; Handa, M.; Ihle, J. N. Functional Interaction of Stat5 and Nuclear Receptor Co-Repressor Smrt: Implications in Negative Regulation of Stat5-Dependent Transcription. Embo J. 2001, 20, 6836-6844.
65. Kaplan, D. H.; Shankaran, V.; Dighe, A. S.; Stockert, E.; Aguet, M.; Old, L. J.; Schreiber, R. D. Demonstration of an Interferon Gamma-Dependent Tumor Surveillance System in Immunocompetent Mice. Proc. Natl. Acad. Sci. USA 1998, 95, 7556-7561.
66. Kulaeva, O. I.; Draghici, S.; Tang, L.; Kraniak, J. M.; Land, S. J.; Tainsky, M. A. Epigenetic Silencing of Multiple Interferon Pathway Genes after Cellular Immortalization. Oncogene 2003, 22, 4118-4127.
67. Missiaglia, E.; Donadelli, M.; Palmieri, M.; Crnogorac-Jurcevic, T.; Scarpa, A.; Lemoine, N. R. Growth Delay of Human Pancreatic Cancer Cells by Methylase Inhibitor 5-Aza-2′-Deoxycytidine Treatment Is Associated with Activation of the Interferon Signalling Pathway. Oncogene 2005, 24, 199-211.
68. Colamonici, O. R.; Domanski, P.; Platanias, L. C.; Diaz, M. O. Correlation between Interferon (Ifn) Alpha Resistance and Deletion of the Ifn Alpha/Beta Genes in Acute Leukemia Cell Lines Suggests Selection against the Ifn System. Blood 1992, 80, 744-749.
69. Billard, C.; Sigaux, F.; Castaigne, S.; Valensi, F.; Flandrin, G.; Degos, L.; Falcoff, E.; Aguet, M. Treatment of Hairy Cell Leukemia with Recombinant Alpha Interferon: Ii. In Vivo Down-Regulation of Alpha Interferon Receptors on Tumor Cells. Blood 1986, 67, 821-826.
70. Abril, E.; Real, L. M.; Serrano, A.; Jimenez, P.; Garcia, A.; Canton, J.; Trigo, I.; Garrido, F.; Ruiz-Cabello, F. Unresponsiveness to Interferon Associated with Stat1 Protein Deficiency in a Gastric Adenocarcinoma Cell Line. Cancer Immunol. Immunother. 1998, 47, 113-120.
71. Clifford, J. L.; Walch, E.; Yang, X.; Xu, X.; Alberts, D. S.; Clayman, G. L.; El-Naggar, A. K.; Lotan, R.; Lippman, S. M. Suppression of Type I Interferon Signaling Proteins Is an Early Event in Squamous Skin Carcinogenesis. Clin. Cancer Res. 2002, 8, 2067-2072.
72. Landolfo, S.; Guarini, A.; Riera, L.; Gariglio, M.; Gribaudo, G.; Cignetti, A.; Cordone, I.; Montefusco, E.; Mandelli, F.; Foa, R. Chronic Myeloid Leukemia Cells Resistant to Interferon-Alpha Lack Stat1 Expression. Hematol. J. 2000, 1, 7-14.
73. Wong, L. H.; Krauer, K. G.; Hatzinisiriou, I.; Estcourt, M. J.; Hersey, P.; Tam, N. D.; Edmondson, S.; Devenish, R. J.; Ralph, S. J. Interferon-Resistant Human Melanoma Cells Are Deficient in Isgf3 Components, Stat1, Stat2, and P48-Isgf3gamma. J. Biol. Chem. 1997, 272, 28779-28785.
74. Huang, S.; Bucana, C. D.; Van Arsdall, M.; Fidler, I. J. Stat1 Negatively Regulates Angiogenesis, Tumorigenicity and Metastasis of Tumor Cells. Oncogene 2002, 21, 2504-2512.
75. Chin, Y. E.; Kitagawa, M.; Su, W. C.; You, Z. H.; Iwamoto, Y.; Fu, X. Y. Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor P21 Waf1/Cip1 Mediated by Stat1. Science 1996, 272, 719-722.
76. Chin, Y. E.; Kitagawa, M.; Kuida, K.; Flavell, R. A.; Fu, X. Y. Activation of the Stat Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis. Mol. Cell Biol. 1997, 17, 5328-5337.
77. Kumar, A.; Commane, M.; Flickinger, T. W.; Horvath, C. M.; Stark, G. R. Defective Tnf-Alpha-Induced Apoptosis in Stat1-Null Cells Due to Low Constitutive Levels of Caspases. Science 1997, 278, 1630-1632.
78. Khodarev, N. N.; Beckett, M.; Labay, E.; Darga, T.; Roizman, B.; Weichselbaum, R. R. Stat1 Is Overexpressed in Tumors Selected for Radioresistance and Confers Protection from Radiation in Transduced Sensitive Cells. Proc. Natl. Acad. Sci. USA 2004, 101, 1714-1719.
79. Roberts, D.; Schick, J.; Conway, S.; Biade, S.; Laub, P. B.; Stevenson, J. P.; Hamilton, T. C.; O'Dwyer, P. J.; Johnson, S. W. Identification of Genes Associated with Platinum Drug Sensitivity and Resistance in Human Ovarian Cancer Cells. Br. J. Cancer 2005, 6, 1149-1158.
80. Karpf, A. R.; Peterson, P. W.; Rawlins, J. T.; Dalley, B. K.; Yang, Q.; Albertsen, H.; Jones, D. A. Inhibition of DNA Methyltransferase Stimulates the Expression of Signal Transducer and Activator of Transcription 1, 2, and 3 Genes in Colon Tumor Cells. Proc. Natl. Acad. Sci. USA 1999, 96, 14007-14012.
81. Chang, Y. E.; Laimins, L. A. Microarray Analysis Identifies Interferon-Inducible Genes and Stat-1 as Major Transcriptional Targets of Human Papillomavirus Type 31. J. Virol. 2000, 74, 4174-4182.
82. Leonard, G. T.; Sen, G. C. Restoration of Interferon Responses of Adenovirus E1a-Expressing Ht1080 Cell Lines by Overexpression of P48 Protein. J. Virol. 1997, 71, 5095-5101.
83. Leonard, G. T.; Sen, G. C. Effects of Adenovirus E1a Protein on Interferon-Signaling. Virology 1996, 224, 25-33.
84. Look, D. C.; Roswit, W. T.; Frick, A. G.; Gris-Alevy, Y.; Dickhaus, D. M.; Walter, M. J.; Holtzman, M. J. Direct Suppression of Stat1 Function During Adenoviral Infection. Immunity 1998, 9, 871-880.
85. Shirasawa, S.; Furuse, M.; Yokoyama, N.; Sasazuki, T. Altered Growth of Human Colon Cancer Cell Lines Disrupted at Activated Ki-Ras. Science 1993, 260, 85-88.
86. Shou, J.; Soriano, R.; Hayward, S. W.; Cunha, G. R.; Williams, P. M.; Gao, W. Q. Expression Profiling of a Human Cell Line Model of Prostatic Cancer Reveals a Direct Involvement of Interferon Signaling in Prostate Tumor Progression. Proc. Natl. Acad. Sci. USA 2002, 99, 2830-2835.
87. Anwar, K.; Nakakuki, K.; Shiraishi, T.; Naiki, H.; Yatani, R.; Inuzuka, M. Presence of Ras Oncogene Mutations and Human Papillomavirus DNA in Human Prostate Carcinomas. Cancer Res. 1992, 52, 5991-5996.
88. Krasilnikov, M.; Ivanov, V. N.; Dong, J.; Ronai, Z. Erk and Pi3k Negatively Regulate Stat-Transcriptional Activities in Human Melanoma Cells: Implications Towards Sensitization to Apoptosis. Oncogene 2003, 22, 4092-4101.
89. Huang, Y.; Horvath, C. M.; Waxman, S. Regrowth of 5-Fluorouracil-Treated Human Colon Cancer Cells Is Prevented by the Combination of Interferon Gamma, Indomethacin, and Phenylbutyrate. Cancer Res. 2000, 60, 3200-3206.
90. Gil, M. P.; Bohn, E.; O'Guin, A. K.; Ramana, C. V.; Levine, B.; Stark, G. R.; Virgin, H. W.; Schreiber, R. D. Biologic Consequences of Stat1-Independent Ifn Signaling. Proc. Natl. Acad. Sci. USA 2001, 98, 6680-6685.
91. Ramana, C. V.; Grammatikakis, N.; Chernov, M.; Nguyen, H.; Goh, K. C.; Williams, B. R.; Stark, G. R. Regulation of C-Myc Expression by Ifn-Gamma through Stat1-Dependent and -Independent Pathways. Embo J. 2000, 19, 263-272.
92. Ramana, C. V.; Gil, M. P.; Schreiber, R. D.; Stark, G. R. Stat1-Dependent and -Independent Pathways in Ifn-Gamma-Dependent Signaling. Trends Immunol. 2002, 23, 96-101.
93. Choi, E. A.; Lei, H.; Maron, D. J.; Wilson, J. M.; Barsoum, J.; Fraker, D. L.; El-Deiry, W. S.; Spitz, F. R. Stat1-Dependent Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and the Cell-Surface Death Signaling Pathway by Interferon Beta in Human Cancer Cells. Cancer Res. 2003, 63, 5299-5307.
94. Ikeda, H.; Old, L. J.; Schreiber, R. D. The Roles of Ifn Gamma in Protection against Tumor Development and Cancer Immunoediting. Cytokine Growth Factor Rev. 2002, 13, 95-109.
95. Qing, Y.; Stark, G. R. Alternative Activation of Stat1 and Stat3 in Response to Interferon-Gamma. J. Biol. Chem. 2004, 279, 41679 - 41685.
96. Widschwendter, A.; Tonko-Geymayer, S.; Welte, T.; Daxenbichler, G.; Marth, C.; Doppler, W. Prognostic Significance of Signal Transducer and Activator of Transcription 1 Activation in Breast Cancer. Clin. Cancer Res. 2002, 8, 3065-3074.
97. Primiano, T.; Baig, M.; Maliyekkel, A.; Chang, B. D.; Fellars, S.; Sadhu, J.; Axenovich, S. A.; Holzmayer, T. A.; Roninson, I. B. Identification of Potential Anticancer Drug Targets through the Selection of Growth-Inhibitory Genetic Suppressor Elements. Cancer Cell 2003, 4, 41-53.
98. Song, J. I.; Grandis, J. R. Stat Signaling in Head and Neck Cancer. Oncogene 2000, 19, 2489-2495.
99. Catlett-Falcone, R.; Landowski, T. H.; Oshiro, M. M.; Turkson, J.; Levitzki, A.; Savino, R.; Ciliberto, G.; Moscinski, L.; Fernandez-Luna, J. L.; Nunez, G.; Dalton, W. S.; Jove, R. Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells. Immunity 1999, 10, 105-115.
100. Yoshikawa, H.; Matsubara, K.; Qian, G. S.; Jackson, P.; Groopman, J. D.; Manning, J. E.; Harris, C. C.; Herman, J. G. Socs-1, a Negative Regulator of the Jak/Stat Pathway, Is Silenced by Methylation in Human Hepatocellular Carcinoma and Shows Growth-Suppression Activity. Nat. Genet. 2001, 28, 29-35.
101. Galm, O.; Yoshikawa, H.; Esteller, M.; Osieka, R.; Herman, J. G. Socs-1, a Negative Regulator of Cytokine Signaling, Is Frequently Silenced by Methylation in Multiple Myeloma. Blood 2003, 101, 2784-2788.
102. Cao, X.; Tay, A.; Guy, G. R.; Tan, Y. H. Activation and Association of Stat3 with Src in V-Src-Transformed Cell Lines. Mol. Cell Biol. 1996, 16, 1595-1603.
103. Yu, C. L.; Meyer, D. J.; Campbell, G. S.; Larner, A. C.; Carter-Su, C.; Schwartz, J.; Jove, R. Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein. Science 1995, 269, 81-83.
104. Turkson, J.; Bowman, T.; Garcia, R.; Caldenhoven, E.; De Groot, R. P.; Jove, R. Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation. Mol. Cell Biol. 1998, 18, 2545-2552.
105. Bromberg, J. F.; Wrzeszczynska, M. H.; Devgan, G.; Zhao, Y.; Pestell, R. G.; Albanese, C.; Darnell, J. E., Jr. Stat3 as an Oncogene. Cell 1999, 98, 295-303.
106. Bowman, T.; Garcia, R.; Turkson, J.; Jove, R. Stats in Oncogenesis. Oncogene 2000, 19, 2474-2488.
107. Turkson, J.; Jove, R. Stat Proteins: Novel Molecular Targets for Cancer Drug Discovery. Oncogene 2000, 19, 6613-6626.
108. Niu, G.; Heller, R.; Catlett-Falcone, R.; Coppola, D.; Jaroszeski, M.; Dalton, W.; Jove, R.; Yu, H. Gene Therapy with Dominant-Negative Stat3 Suppresses Growth of the Murine Melanoma B16 Tumor in Vivo. Cancer Res. 1999, 59, 5059-5063.
109. Xi, S.; Gooding, W. E.; Grandis, J. R. In Vivo Antitumor Efficacy of Stat3 Blockade Using a Transcription Factor Decoy Approach: Implications for Cancer Therapy. Oncogene 2004, 24, 970-979.
110. Chan, K. S.; Sano, S.; Kiguchi, K.; Anders, J.; Komazawa, N.; Takeda, J.; DiGiovanni, J. Disruption of Stat3 Reveals a Critical Role in Both the Initiation and the Promotion Stages of Epithelial Carcinogenesis. J. Clin. Invest. 2004, 114, 720-728.
111. Aoki, Y.; Feldman, G. M.; Tosato, G. Inhibition of Stat3 Signaling Induces Apoptosis and Decreases Survivin Expression in Primary Effusion Lymphoma. Blood 2003, 101, 1535-1542.
112. Bowman, T.; Broome, M. A.; Sinibaldi, D.; Wharton, W.; Pledger, W. J.; Sedivy, J. M.; Irby, R.; Yeatman, T.; Courtneidge, S. A.; Jove, R. Stat3-Mediated Myc Expression Is Required for Src Transformation and Pdgf-Induced Mitogenesis. Proc. Natl. Acad. Sci. USA 2001, 98, 7319-7324.
113. Niu, G.; Wright, K. L.; Huang, M.; Song, L.; Haura, E.; Turkson, J.; Zhang, S.; Wang, T.; Sinibaldi, D.; Coppola, D.; Heller, R.; Ellis, L. M.; Karras, J.; Bromberg, J.; Pardoll, D.; Jove, R.; Yu, H. Constitutive Stat3 Activity up-Regulates Vegf Expression and Tumor Angiogenesis. Oncogene 2002, 21, 2000-2008.
114. Wei, L. H.; Kuo, M. L.; Chen, C. A.; Chou, C. H.; Lai, K. B.; Lee, C. N.; Hsieh, C. Y. Interleukin-6 Promotes Cervical Tumor Growth by Vegf-Dependent Angiogenesis Via a Stat3 Pathway. Oncogene 2003, 22, 1517-1527.
115. Yahata, Y.; Shirakata, Y.; Tokumaru, S.; Yamasaki, K.; Sayama, K.; Hanakawa, Y.; Detmar, M.; Hashimoto, K. Nuclear Translocation of Phosphorylated Stat3 Is Essential for Vascular Endothelial Growth Factor-Induced Human Dermal Microvascular Endothelial Cell Migration and Tube Formation. J. Biol. Chem. 2003, 278, 40026-40031.
116. Rivat, C.; Rodrigues, S.; Bruyneel, E.; Pietu, G.; Robert, A.; Redeuilh, G.; Bracke, M.; Gespach, C.; Attoub, S. Implication of Stat3 Signaling in Human Colonic Cancer Cells During Intestinal Trefoil Factor 3 (Tff3) - and Vascular Endothelial Growth Factor-Mediated Cellular Invasion and Tumor Growth. Cancer Res. 2005, 65, 195-202.
117. Wang, T.; Niu, G.; Kortylewski, M.; Burdelya, L.; Shain, K.; Zhang, S.; Bhattacharya, R.; Gabrilovich, D.; Heller, R.; Coppola, D.; Dalton, W.; Jove, R.; Pardoll, D.; Yu, H. Regulation of the Innate and Adaptive Immune Responses by Stat-3 Signaling in Tumor Cells. Nat. Med. 2004, 10, 48-54.
118. Nefedova, Y.; Huang, M.; Kusmartsev, S.; Bhattacharya, R.; Cheng, P.; Salup, R.; Jove, R.; Gabrilovich, D. Hyperactivation of Stat3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer. J. Immunol. 2004, 172, 464-474.
119. Horiguchi, A.; Oya, M.; Shimada, T.; Uchida, A.; Marumo, K.; Murai, M. Activation of Signal Transducer and Activator of Transcription 3 in Renal Cell Carcinoma: A Study of Incidence and Its Association with Pathological Features and Clinical Outcome. J. Urol. 2002, 168, 762-765.
120. Masuda, M.; Suzui, M.; Yasumatu, R.; Nakashima, T.; Kuratomi, Y.; Azuma, K.; Tomita, K.; Komiyama, S.; Weinstein, I. B. Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Cyclin D1 Overexpression and May Provide a Novel Prognostic Marker in Head and Neck Squamous Cell Carcinoma. Cancer Res. 2002, 62, 3351-3355.
121. Benekli, M.; Xia, Z.; Donohue, K. A.; Ford, L. A.; Pixley, L. A.; Baer, M. R.; Baumann, H.; Wetzler, M. Constitutive Activity of Signal Transducer and Activator of Transcription 3 Protein in Acute Myeloid Leukemia Blasts Is Associated with Short Disease-Free Survival. Blood 2002, 99, 252-257.
122. Khoury, J. D.; Medeiros, L. J.; Rassidakis, G. Z.; Yared, M. A.; Tsioli, P.; Leventaki, V.; Schmitt-Graeff, A.; Herling, M.; Amin, H. M.; Lai, R. Differential Expression and Clinical Significance of Tyrosine-Phosphorylated Stat3 in Alk+ and Alk- Anaplastic Large Cell Lymphoma. Clin. Cancer Res. 2003, 9, 3692-3699.
123. Dolled-Filhart, M.; Camp, R. L.; Kowalski, D. P.; Smith, B. L.; Rimm, D. L. Tissue Microarray Analysis of Signal Transducers and Activators of Transcription 3 (Stat3) and Phospho-Stat3 (Tyr705) in Node-Negative Breast Cancer Shows Nuclear Localization Is Associated with a Better Prognosis. Clin. Cancer Res. 2003, 9, 594-600.
124. Hsiao, J. R.; Jin, Y. T.; Tsai, S. T.; Shiau, A. L.; Wu, C. L.; Su, W. C. Constitutive Activation of Stat3 and Stat5 Is Present in the Majority of Nasopharyngeal Carcinoma and Correlates with Better Prognosis. Br. J. Cancer 2003, 89, 344-349.
125. Moriggl, R.; Sexl, V.; Kenner, L.; Duntsch, C.; Stangl, K.; Gingras, S.; Hoffmeyer, A.; Bauer, A.; Piekorz, R.; Wang, D.; Bunting, K. D.; Wagner, E. F.; Sonneck, K.; Valent, P.; Ihle, J. N.; Beug, H. Stat5 Tetramer Formation Is Associated with Leukemogenesis. Cancer Cell 2005, 7, 87-99.
126. Yamashita, H.; Nishio, M.; Fujii, Y.; Iwase, H. Dominant-Negative Stat5 Inhibits Growth and Induces Apoptosis in T47d-Derived Tumors in Nude Mice. Cancer Sci. 2004, 95, 662-665.
127. Ren, S.; Cai, H. R.; Li, M.; Furth, P. A. Loss of Stat5a Delays Mammary Cancer Progression in a Mouse Model. Oncogene 2002, 21, 4335-4339.
128. Maurer, A. B.; Wichmann, C.; Gross, A.; Kunkel, H.; Heinzel, T.; Ruthardt, M.; Groner, B.; Grez, M. The Stat5-Raralpha Fusion Protein Represses Transcription and Differentiation through Interaction with a Corepressor Complex. Blood 2002, 99, 2647-2652.
129. Levine, R. L.; Wadleigh, M.; Cools, J.; Ebert, B. L.; Wernig, G.; Huntly, B. J.; Boggon, T. J.; Wlodarska, I.; Clark, J. J.; Moore, S.; Adelsperger, J.; Koo, S.; Lee, J. C.; Gabriel, S.; Mercher, T.; D'Andrea, A.; Frohling, S.; Dohner, K.; Marynen, P.; Vandenberghe, P.; Mesa, R. A.; Tefferi, A.; Griffin, J. D.; Eck, M. J.; Sellers, W. R.; Meyerson, M.; Golub, T. R.; Lee, S. J.; Gilliland, D. G. Activating Mutation in the Tyrosine Kinase Jak2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia with Myelofibrosis. Cancer Cell 2005, 7, 387-397.
130. James, C.; Ugo, V.; Le Couedic, J. P.; Staerk, J.; Delhommeau, F.; Lacout, C.; Garcon, L.; Raslova, H.; Berger, R.; Bennaceur-Griscelli, A.; Villeval, J. L.; Constantinescu, S. N.; Casadevall, N.; Vainchenker, W. A Unique Clonal Jak2 Mutation Leading to Constitutive Signalling Causes Polycythaemia Vera. Nature 2005, 434, 1144-1148.
131. Steensma, D. P.; Dewald, G. W.; Lasho, T. L.; Powell, H. L.; McClure, R. F.; Levine, R. L.; Gilliland, D. G.; Tefferi, A. The Jak2 V617f Activating Tyrosine Kinase Mutation Is an Infrequent Event in Both "Atypical" Myeloproliferative Disorders and the Myelodysplastic Syndrome. Blood 2005.
132. Musso, A.; Dentelli, P.; Carlino, A.; Chiusa, L.; Repici, A.; Sturm, A.; Fiocchi, C.; Rizzetto, M.; Pegoraro, L.; Sategna-Guidetti, C.; Brizzi, M. F. Signal Transducers and Activators of Transcription 3 Signaling Pathway: An Essential Mediator of Inflammatory Bowel Disease and Other Forms of Intestinal Inflammation. Inflamm. Bowel Dis. 2005, 11, 91-98.
133. Mudter, J.; Weigmann, B.; Bartsch, B.; Kiesslich, R.; Strand, D.; Galle, P. R.; Lehr, H. A.; Schmidt, J.; Neurath, M. F. Activation Pattern of Signal Transducers and Activators of Transcription (Stat) Factors in Inflammatory Bowel Diseases. Am. J. Gastroenterol. 2005, 100, 64-72.
134. Schreiber, S.; Rosenstiel, P.; Hampe, J.; Nikolaus, S.; Groessner, B.; Schottelius, A.; Kuhbacher, T.; Hamling, J.; Folsch, U. R.; Seegert, D. Activation of Signal Transducer and Activator of Transcription (Stat) 1 in Human Chronic Inflammatory Bowel Disease. Gut 2002, 51, 379-385.
135. Epling-Burnette, P. K.; Liu, J. H.; Catlett-Falcone, R.; Turkson, J.; Oshiro, M.; Kothapalli, R.; Li, Y.; Wang, J. M.; Yang-Yen, H. F.; Karras, J.; Jove, R.; Loughran, T. P., Jr. Inhibition of Stat3 Signaling Leads to Apoptosis of Leukemic Large Granular Lymphocytes and Decreased Mcl-1 Expression. J. Clin. Invest. 2001, 107, 351-362.
136. Thomas, M.; Finnegan, C. E.; Rogers, K. M.; Purcell, J. W.; Trimble, A.; Johnston, P. G.; Boland, M. P. Stat1: A Modulator of Chemotherapy-Induced Apoptosis. Cancer Res. 2004, 64, 8357-8364.
137. Nikitakis, N. G.; Hamburger, A. W.; Sauk, J. J. The Nonsteroidal Anti-Inflammatory Drug Sulindac Causes Down-Regulation of Signal Transducer and Activator of Transcription 3 in Human Oral Squamous Cell Carcinoma Cells. Cancer Res. 2002, 62, 1004-1007.
138. Park, E. J.; Park, S. Y.; Joe, E. H.; Jou, I. 15d-PGJ2 and Rosiglitazone Suppress Janus Kinase-Stat Inflammatory Signaling through Induction of Suppressor of Cytokine Signaling 1 (Socs1) and Socs3 in Glia. J. Biol. Chem. 2003, 278, 14747-14752.
139. Kim, H. Y.; Park, E. J.; Joe, E. H.; Jou, I. Curcumin Suppresses Janus Kinase-Stat Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia. J. Immunol. 2003, 171, 6072-6079.
140. Blaskovich, M. A.; Sun, J.; Cantor, A.; Turkson, J.; Jove, R.; Sebti, S. M. Discovery of Jsi-124 (Cucurbitacin I), a Selective Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathway Inhibitor with Potent Antitumor Activity against Human and Murine Cancer Cells in Mice. Cancer Res. 2003, 63, 1270-1279.
141. Sun, J.; Blaskovich, M. A.; Jove, R.; Livingston, S. K.; Coppola, D.; Sebti, S. M. Cucurbitacin Q: A Selective Stat3 Activation Inhibitor with Potent Antitumor Activity. Oncogene 2005, 24, 3236-3245.
142. Turkson, J.; Zhang, S.; Palmer, J.; Kay, H.; Stanko, J.; Mora, L. B.; Sebti, S.; Yu, H.; Jove, R. Inhibition of Constitutive Signal Transducer and Activator of Transcription 3 Activation by Novel Platinum Complexes with Potent Antitumor Activity. Mol. Cancer Ther. 2004, 3, 1533-1542.
143. Leong, P. L.; Andrews, G. A.; Johnson, D. E.; Dyer, K. F.; Xi, S.; Mai, J. C.; Robbins, P. D.; Gadiparthi, S.; Burke, N. A.; Watkins, S. F.; Grandis, J. R. Targeted Inhibition of Stat3 with a Decoy Oligonucleotide Abrogates Head and Neck Cancer Cell Growth. Proc. Natl. Acad. Sci. USA 2003, 100, 4138-4143.
144. Xi, S.; Gooding, W. E.; Grandis, J. R. In Vivo Antitumor Efficacy of Stat3 Blockade Using a Transcription Factor Decoy Approach: Implications for Cancer Therapy. Oncogene 2005, 24, 970-979.
145. Alas, S.; Bonavida, B. Rituximab Inactivates Signal Transducer and Activation of Transcription 3 (Stat3) Activity in B-Non-Hodgkin's Lymphoma through Inhibition of the Interleukin 10 Autocrine/Paracrine Loop and Results in Down-Regulation of Bcl-2 and Sensitization to Cytotoxic Drugs. Cancer Res. 2001, 61, 5137-5144.
146. Alas, S.; Bonavida, B. Inhibition of Constitutive Stat3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-Mediated Apoptosis. Clin. Cancer Res. 2003, 9, 316-326.
147. Jing, N.; Li, Y.; Xiong, W.; Sha, W.; Jing, L.; Tweardy, D. J. G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis. Cancer Res. 2004, 64, 6603-6609.
148. Sordella, R.; Bell, D. W.; Haber, D. A.; Settleman, J. Gefitinib-Sensitizing Egfr Mutations in Lung Cancer Activate Anti-Apoptotic Pathways. Science 2004, 305, 1163-1167.